![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Japan's Takeda Buys California Biotechnology Company for US$270 Million
Japan's Takeda Buys California Biotechnology Company for US$270 Million
Japan's largest drugmaker, Takeda Pharmaceutical, will acquire Syrrx, a privately held California biotechnology company working on treatments for cancer and diabetes, for roughly US$270 million in cash. The purchase will give Takeda access to high-level talent and new medical research innovations. The Japanese company was also eager to have a research base in the U.S., the world's largest pharmaceutical market and a center for medical research.
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct